Catramilast

Catramilast is a PDE4D inhibitor. Catramilast can be used in pain research[1].

Product Specifications

CAS Number

183659-72-5

UNSPSC

12352005

Target

Phosphodiesterase (PDE)

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Neurological Disease

Smiles

COC(C=CC([C@H](C)CN1C(NC=C1)=O)=C2)=C2OCC3CC3

Molecular Formula

C17H22N2O3

Molecular Weight

302.37

References & Citations

[1]Class IP, USPC A. Patent application title: Compounds and methods for treating pain inventors: Josef Penninger (Vienna, AT) Josef Penninger (Vienna, AT) Graham Gregory Neely (Sydney, AU) Shane Mcmanus (Vienna, AT) Henrik Nilsson (Vienna, AT) . The Journal of Pharmacology and Experimental Therapeutics. 2013 Sep 26.